An induced pluripotent stem cell line (CIMRi001-A) from a Vici syndrome donor with a homozygous recessive c.1007A>G (p.Q336R) mutation in the EPG5 gene

被引:2
|
作者
Mitchell, Matthew W. [1 ]
Grandizio, Christine [1 ]
Turan, Nahid [1 ]
Requesens, Deborah V. [1 ,2 ]
机构
[1] Coriell Inst Med Res, Camden, NJ 08103 USA
[2] Univ Penn, Orphan Dis Ctr, Perelman Sch Med, Philadelphia, PA 19104 USA
关键词
D O I
10.1016/j.scr.2022.102833
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Vici syndrome is a rare, congenital disorder that affects multiple systems and is caused by mutations in the EPG5 gene that encodes for ectopic P-granules autophagy protein 5 (EPG5). The induced pluripotent stem cell (iPSC) line described here was generated from a dermal fibroblast cell line from an 8-year-old male donor with a homozygous recessive c.1007A > G (p.Q336R) mutation in the EPG5 gene. This iPSC model of Vici syndrome provides a unique and valuable resource for investigators to study the pathology of EPG5 mutations and the aetiology of the disease as well as develop therapeutic treatments for those with Vici syndrome.
引用
收藏
页数:5
相关论文
共 49 条
  • [31] Generation of an integration-free induced pluripotent stem cell line, FJMUUHi002-A, from a Rett syndrome patient with a heterozygous mutation p. R133C in MeCP2
    Guo, Yu
    Li, Jiaqi
    Xie, Wenyi
    Huang, Huaping
    Li, Jin-Jing
    Lin, Wanhui
    Lu, Ying-Qian
    STEM CELL RESEARCH, 2024, 74
  • [32] Establishment and characterization of ZJUCHi003: an induced pluripotent stem cell line from a patient with Temple–Baraitser/Zimmermann–Laband syndrome carrying KCNH1 c.1070G > A (p.R357Q) variant
    Die Chen
    Jimei Su
    Xueying Huang
    Hongyu Chen
    Tiejia Jiang
    Chunchun Zhi
    Zuolin Zhou
    Bing Zhang
    Lan Yu
    Xiaoling Jiang
    Human Cell, 2024, 37 : 832 - 839
  • [33] Human induced pluripotent stem cell line (ONHi001-A) generated from a patient with infantile neuroaxonal dystrophy having PLA2G6 c.517C > T (p.Q173X) and c.1634A > G (p.K545R) compound heterozygous mutations
    Fukusumi, Hayato
    Togo, Kazuyuki
    Beck, Goichi
    Shofuda, Tomoko
    Kanematsu, Daisuke
    Yamamoto, Atsuyo
    Sumida, Miho
    Baba, Kousuke
    Mochizuki, Hideki
    Kanemura, Yonehiro
    STEM CELL RESEARCH, 2023, 69
  • [34] Generation of an urine-derived induced pluripotent stem cell line WMUi017-A from a X-linked Renpenning syndrome (X-RSY) patient with the hemizygous PQBP1 gene mutation p.P609A (c.1825C>G)
    Guo, Xiaoling
    Zhang, Xufei
    Wang, Linlin
    He, Lingyun
    Ding, Yinjuan
    Chen, Huihui
    Wang, Dexuan
    Rong, Xing
    Shen, Xian
    Lin, Jian
    Chu, Maoping
    STEM CELL RESEARCH, 2021, 51
  • [35] Generation of a human induced pluripotent stem cell line (CMCi001-A) from a patient with karyomegalic interstitial nephritis with homozygous frameshift deletion mutation c.1985_1994del10 of the FANCD2/FANCI-Associated Nuclease 1 gene
    Na, Do Hyun
    Lim, Sun Woo
    Kim, Bo-Mi
    Kim, Kyoung Woon
    Shin, Yoo Jin
    Chae, Hyojin
    Ko, Eun Jeong
    Yang, Chul Woo
    Kim, Myungshin
    Ha Chung, Byung
    STEM CELL RESEARCH, 2020, 46
  • [36] The generation of an induced pluripotent stem cell line (DCGi001-A) from an individual with FOXG1 syndrome carrying the c.460dupG (p.Glu154fs) variation in the FOXG1 gene
    Waite, Adrian J.
    Millar, David
    Clarke, Angus
    STEM CELL RESEARCH, 2020, 49
  • [37] Generation of the human induced pluripotent stem cell line (UKWNLi001-A) from skin fibroblasts of a woman with Fabry disease carrying the X-chromosomal heterozygous c.708 G > C (W236C) missense mutation in exon 5 of the alpha-galactosidase-A gene
    Klein, Thomas
    Guenther, Katharina
    Kwok, Chee Keong
    Edenhofer, Frank
    Ueceyler, Nurcan
    STEM CELL RESEARCH, 2018, 31 : 222 - 226
  • [38] An induced pluripotent stem cell line (TRNDi001-D) from a Niemann-Pick disease type C1 (NPC1) patient carrying a homozygous p. I1061T (c. 3182 T>C ) mutation in the NPC1 gene
    Li, Rong
    Pradhan, Manisha
    Xu, Miao
    Roeder, Amanda
    Beers, Jeanette
    Zou, Jizhong
    Liu, Chengyu
    Porter, Forbes D.
    Zhen, Wei
    STEM CELL RESEARCH, 2020, 44
  • [39] Reprogramming of a human induced pluripotent stem cell (iPSC) line (IBMSi012-A) from an early-onset Parkinson's disease patient harboring a homozygous p.D331Y mutation in the PLA2G6 gene
    Cheng, Yu-Che
    Lin, Han-, I
    Syu, Shih-Han
    Lu, Huai-En
    Huang, Ching-Ying
    Lin, Chin-Hsien
    Hsieh, Patrick C. H.
    STEM CELL RESEARCH, 2019, 37
  • [40] Generation of an integration-free induced pluripotent stem cell line (PUMCHi001-A) from a patient with familial partial lipodystrophy type 2 (FPLD2) carrying a heterozygous p.R349W (c.1045C > T) mutation in the LMNA gene
    Xiao, Cheng
    Yu, Miao
    Liu, Jieying
    Wu, Han
    Deng, Mingqun
    Zhang, Qian
    Xiao, Xinhua
    STEM CELL RESEARCH, 2020, 42